舒利迭联合金水宝胶囊治疗慢性阻塞性肺疾病的临床观察

目的:观察沙美特罗氟替卡松吸入剂和金水宝胶囊联合治疗中度以上慢性阻塞性肺疾病(COPD)稳定期患者的临床疗效。方法:采用前瞻性研究方法将60例缓解期慢性阻塞性肺疾病患者随机分成对照组30例和实验组30例,治疗12周后,评价所有患者的运动耐力、血气分析与肺功能指标等。结果:对照组与实验组上述指标均较治疗前改善(P【0.05与P【0.01),但实验组较对照组改善更为明显(P【0.05)。结论:舒利迭联合金水宝胶囊治疗慢性阻塞性肺疾病疗效显著,能提高运动耐力、改善动脉血气、促进肺功能的恢复。

Objective:To investigate the clinical efficacy of Seretide in combination with Jinshui treasure capsule in moderate COPD in stable period.Method:Randomly divide 60 cases into control group and experimental group,Endurance ratings,blood gas analysis and parameters of pulmonary function(FEV1,FEV1/FVC)of all patients were assessed after 12 weeks’ treatment.Result:Compared with prior treatment,all indicators above of the two group improved a lot(P<0.05,P<0.01),but treatment group was even more apparent than control group(P<0.05).Conclusion:Combined Seretide and Jinshui treasure capsule has a significant effect on the treatment in moderate COPD in stable period patients by enhanceing endurance ratings,improving blood gas and promoting the recovery of pulmonary function.